News

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
An intra-aortic balloon pump (IABP) is a type of mechanical device used to assist blood flow. It's implanted into the body's largest blood vessel ( aorta ), and inflates and deflates with each ...
Researchers report that the elective use of IABP during PCI was associated with a 34% reduction in the risk of death after a median follow-up of 51 months. They were cautious in interpreting the ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
Indications for intra-aortic balloon pump use as reflected in the Benchmark Registry. Total population (n = 16,909; %) Diagnostic catheterization only (n = 1576; %) ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in several million ...
After PCI, they were randomized 1:1 to IABP or no IABP for 12 to 24 hours. Mean duration of IABP use was 15 hours. By 6-month follow-up, one patient in the IABP group had experienced a primary ...
Intra-aortic balloon pump combined with mechanical ventilation for treating patients aged > 60 years in cardiogenic shock: Retrospective analysis, Journal of International Medical Research, 44, 3 ...
On the other hand, the impact of IABP therapy trended the wrong way in infarct size estimated by CK-MB (338 U/L for IABP versus 311 U/L for control, P=0.532), according to Lokien van Nunen, ...
The addition to the IABP family supports uncompromised cardiac support for patients during transportWAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading ...
IV iron supplementation in HFrEF patients showed a 21% reduction in cardiovascular death or first HF hospitalization, despite not meeting primary endpoints. Intra-aortic balloon pump did not ...